Effects of nutraceutical diet integration, with coenzyme Q10 (Q-Ter multicomposite) and creatine, on dyspnea, exercise tolerance, and quality of life in COPD patients with chronic respiratory failure

Multidisciplinary Respiratory Medicine

Volumn 8, Issue 5, 2013, Pages

  Marinari, Stefano ^a   Manigrasso, Maria Rosaria ^a   De Benedetto, Fernando ^a  

^a SS Annunziata Hospital   (Italy)

Author keywords

Chronic respiratory failure; COPD; Creatine; Dyspnea; Exercise tolerance; Q Ter; Quality of life

Indexed keywords

CREATINE; EUFORTYN; NUTRACEUTICAL; UBIDECARENONE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY FAILURE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIET; DIET SUPPLEMENTATION; DYSPNEA; EXERCISE TOLERANCE; FOLLOW UP; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; QUALITY OF LIFE; RESPIRATORY FUNCTION; TELECONSULTATION;

EID: 84879900688     PISSN: 1828695X     EISSN: 20496958     Source Type: Journal    
DOI: 10.1186/2049-6958-8-40     Document Type: Article

References (71)

1. Schols AMWJ, Broekhuizen R, Weling-Sheepers CA, Wouters EF: Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005, 82:53-59. (Pubitemid 41716377)
2. Marquis K, Debigaré R, Lacasse Y, LeBlanc P, Jobin J, Carrier G, Maltais F: Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002, 166:809-813.
3. Chailleux E, Laaban JP, Veale D: Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest 2003, 123:1460-1466. (Pubitemid 36549763)
4. De Benedetto F, Del Ponte A, Cervone L, Cisternino R, Marinari S, Sbrogia M: Is any relationship between body weight and severity of COPD? Retrospective large population study. Am Rev Respir Dis 1990(suppl. 141):A35.
5. American Thoracic Society/European Respiratory Society: Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 159:S1-S40.
6. Decramer M, De Benedetto F, Del Ponte A, Marinari S: Systemic effects of COPD. Respir Med 2005, 99(Suppl B):S3-S10. (Pubitemid 41700139)
7. De Benedetto F, Bitti G, D'Intino D, Marinari S, Del Ponte A: Body weight alone is not an index of nutritional imbalance in the natural course of chronic obstructive lung disease. Monaldi Arch. Chest Dis 1993, 48(5):541-542. (Pubitemid 24039921)
8. Vestbo J, Prescott E, Almdal T, Morten Dahl N, Andersen T, Sorensen A, Lange A: Body Mass, Fat-Free Body Mass and prognosis in patients with chronic Obstructive pulmonary disease from a random population sample. Am J Respir Crit Care Med 2006, 173:79-83. (Pubitemid 43069791)
9. Schols AM: Pulmonary cachexia. Int J Cardiol 2002, 85:101-110.
10. Broekhuizen R, Grimble RF, Howell WM, Shale DJ, Creutzberg EC, Wouters EF, Schols AM: Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1β-511 single nucleotide polymorphism. Am J Clin Nutr 2005, 82:1059-1064. (Pubitemid 43779765)
11. Hopkinson NS, Eleftheriou KI, Payne J, Nickol AH, Hawe E, Moxham J, Montgomery H, Polkey MI: +9/+9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2006, 83:912-917. (Pubitemid 44713158)
12. Langen RCJ, Schols AMWJ, Kelders MCJM, Van der Velden JLJ, Wouters EFM, Janssen-Heininger YMW: Muscle wasting and impaired muscle regeneration in a murine model of chronic pulmonary inflammation. Am J Respir Cell Mol Biol 2006, 35:689-696. (Pubitemid 44901858)
13. Sergi G, Coin A, Marin S, Vianello A, Manzan A, Peruzza S, Inelmen EM, Busetto L, Mulone S, Enzi G: Body composition and resting energy expenditure in elderly male patients with chronic obstructive pulmonary disease. Respir Med 2006, 100:1918-1924. (Pubitemid 44490294)
14. Wagner PD: Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J 2008, 31:492-501.
15. Takabatake N, Nakamura H, Abe S, Hino T, Saito H, Yuki H, Kato S, Tomoike H: Circulating leptin in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 159:1215-1219. (Pubitemid 29202558)
16. Takabatake N, Nakamura H, Minamihaba O, Inage M, Inoue S, Kagaya S, Yamaki M, Tomoike H: A novel pathophysiologic phenomenon in chachexic patients with chronic obstructive pulmonary disease: the relationship between the circadian rhythm of circulating leptin and the very low-frequency component of heart rate variability. Am J Respir Crit Care Med 2001, 163:1314-1319. (Pubitemid 32506592)
17. Di Francia M, Barbier D, Mege JL, Orehek J: Tumor necrosis factor-α levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994, 150:1453-1455. (Pubitemid 24356667)
18. Eid AA, Ionescu AA, Nixon LS, Lewis-Jenkins V, Matthews SB, Griffiths TL, Shale DJ: Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 164:1414-1418. (Pubitemid 33124019)
19. Itoh T, Nagaya N, Yoshikawa M, Fukuoka A, Takenaka H, Shimizu Y, Haruta Y, Oya H, Yamagishi M, Hosoda H, Kangawa K, Kimura H: Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 170:879-882. (Pubitemid 39346483)
20. Schols AMWJ, Crutzberg EC, Buurman WA, Campfield LA, Saris WHM, Wouters EFM: Plasma leptin is related to proinflammatory staus and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160:1220-1226. (Pubitemid 29487462)
21. Antonucci R, Berton E, Huertas P, Laveneziana P, Palange P: Exercise physiology in COPD. Monaldi Arch Chest Dis 2003, 59(2):134-139. (Pubitemid 37420131)
22. Koechlin C, Couillard A, Simar D, Cristol JP, Bellet H, Hayot M, Prefaut C: Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2004, 169:1022-1027. (Pubitemid 38543641)
23. Gosker HR, Lencer NH, Franssen FM, Van der Vusse GJ, Wouters EF, Schols AM: Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest 2003, 123:1416-1424. (Pubitemid 36549758)
24. Vogiatzis I, Simoes DC, Stratakos G, Kourepini E, Terzia G, Manta P, Athanasopoulos D, Roussos C, Wagner PD, Zakynthinos S: Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD. Eur Respir J 2010, 36:301-310.
25. Rutten EP, Franssen FM, Engelen MP, Wouters EF, Deutz NE, Schols AM: Greater whole-body myofibrillar protein breakdown in cachectic patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2006, 83:829-834. (Pubitemid 44713147)
26. Couillard A, Koechlin C, Cristol JP, Varray A, Prefaut C: Evidence of local exercise- induced systemic oxidative stress in chronic obstructive pulmonary disease. Eur Respir J 2002, 20:1123-1129. (Pubitemid 35331868)
27. Sahebjami H, Sathianpitayakul E: Influence of body weight on the severity of dyspnea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 161:886-890. (Pubitemid 30171747)
28. Naimi AI, Bourbeau J, Perrault H, Baril J, Wright-Paradis C, Rossi A, Taivassalo T, Sheel AW, Rabøl R, Dela F, Boushel R: Altered mitochondrial regulation in quadriceps muscles of patients with COPD. Clin Physiol Funct Imaging 2011, 31(2):124-131.
29. Puente-Maestu L, Pérez-Parra J, Godoy R, Moreno N, Tejedor A, González-Aragoneses F, Bravo JL, Alvarez FV, Camaño S, Agustí A: Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients. Eur Respir J 2009, 33(5):1045 -1052.
30. Slebos DJ, Van der Toorn M, Bakker SJ, Kauffman HF: Mitochondrial dysfunction in COPD patients with low body mass index. Eur Respir J 2007, 30(3):600. author reply 600-1.
31. Gosker HR, Hesselink MK, Duimel H, Ward KA, Schols AM: Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD. Eur Respir J 2007, 30(1):73-79. (Pubitemid 47074009)
32. Rabinovich RA, Bastos R, Ardite E, Llinàs L, Orozco-Levi M, Gea J, Vilaró J, Barberà JA, Rodríguez-Roisin R, Fernández-Checa JC, Roca J: Mitochondrial dysfunction in COPD patients with low body mass index. Eur Respir J 2007, 29(4):643-650. (Pubitemid 46554612)
33. Pajen JF, Wuyam B, Levy P, Reutenauer H, Stieglitz P, Paramelle B, Le Bas JF: Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia. Am Rev Respir Dis 1993, 147:592-598. (Pubitemid 23072647)
34. Faager G, Söderlund K, Sköld CM, Rundgren S, Tollbäck A, Jakobsson P: Creatine supplementation and physical training in patients with COPD: a double blind, placebo-controlled study. Int J Chron Obstruct Pulmon Dis 2006, 1(4):445-453.
35. Tanrikulu AC, Abakay A, Evliyaoglu O, Palanci Y: Coenzyme Q10, copper, zinc, and lipid peroxidation levels in serum of patients with chronic obstructive pulmonary disease. Biol Trace Elem Res 2011, 143(2):659-667.
36. Xu J, Seo AY, Vorobyeva DA, Carter CS, Anton SD, Lezza AM, Leeuwenburgh C: Beneficial effects of a Q-ter based nutritional mixture on functional performance, mitochondrial function, and oxidative stress in rats. PLoS One 2010, 5:e10572.
37. Saremi A, Gharakhanloo R, Sharghi S, Gharaati MR, Larijani B, Omidfar K: Effects of oral creatine and resistance training on serum myostatin and GASP-1. Mol Cell Endocrinol 2010, 317(1-2):25-30.
38. Guarducci L, Fumagalli S, Sforza G, Fattirolli N, Marchionni G: Effetti di un associazione di Coenzima Q10 e creatina sulla tolleranza all'esercizio fisico e sulla qualità della vita di pazienti con scompenso cardiaco. G Gerontol 2006, 5:499.
39. Fumagalli S, Fattirolli F, Guarducci L, Cellai T, Baldasseroni S, Tarantini F, Di Bari M, Masotti G, Marchionni N: Coenzyme Q10 terclatrate and creatine in chronic heart failure: a randomized, placebo controlled, double-blind study. Clin Cardiol 2011, 34:211-217.
40. Fuld JP, Kilduff LP, Neder JA, Pitsiladis Y, Lean MEJ, Ward SA, Cotton MM: Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax 2005, 60:531-537. (Pubitemid 40966204)
41. Bartlett HR, Puhl SM, Hdgson L, Buskirk ER: Fat-free mass in relation to stature: ratios of fat-free mass to height in children, adults end elderly subjects. Am J Clin Nutr 1991, 53:1112-1116.
42. Katz TF: A.D.L. Activities of Daily Living. JAMA 1963, 185:914.
43. Statement ATS: Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med 2002, 166:111-117.
44. Jones PW, Quirk FH, Baveystock CM: The St George's Respiratory Questionnaire. Respir Med 1991, 85(suppl):25-31.
45. Çalikoglu M, Şahin G, Unlu A, Ozturk C, Tamer L, Ercan B, Kanik A, Atik U: Leptin and TNF-Alpha Levels in Patients with Chronic Obstructive Pulmonary Disease and Their Relationship to Nutritional Parameters. Respiration 2004, 71:45-50. (Pubitemid 38223765)
46. Alway SE, Swisher A, Siu PM: Increased expression of apoptotic genes in the diaphragm and soleus muscle of the emphysematous hamster. Faseb J 2004, 18:A358.
47. Bernard S, LeBlanc P, Whittom F, Carrier G, Jobin J, Belleau R, Maltais F: Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 158:629-634. (Pubitemid 28378196)
48. Gosker HR, Kubat B, Schaart G, Van der Vusse GJ, Wouters EF, Schols AM: Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease. Eur Respir J 2003, 22(2):280-285. (Pubitemid 36986998)
49. Palange P, Forte S, Onorati P, Paravati V, Manfredi F, Serra P, Carlone S: Effect of reduced body weight on muscle aerobic capacity in patients with COPD. Chest 1998, 114(1):12-18. (Pubitemid 28337355)
50. Rabinovich RA, Vilaró J: Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 2010, 16(2):123-133.
51. Ribera F, N'Guessan B, Zoll J, Fortin D, Serrurier B, Mettauer B, Bigard X, Ventura-Clapier R, Lampert E: Mitochondrial electron transport chain function is enhanced in inspiratory muscles of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003, 167(6):873-879. (Pubitemid 36801776)
52. Hamaoka T, Tatsumi K, Saito Y, Arai Y, Horie Y, Masuyama S, Tanabe N, Takiguchi Y, Ikehira H, Obata T, Sasaki Y, Tanada S, Kuriyama T: Metabolic activity in skeletal muscles of patients with non-hypoxaemic chronic obstructive pulmonary disease studied by 31P-magnetic resonance spectroscopy. Respirology 2005, 10 (2):164-170. (Pubitemid 40637999)
53. Layec G, Haseler LJ, Richardson RS: The effect of higher ATP cost of contraction on the metabolic response to graded exercise in patients with chronic obstructive pulmonary disease. J Appl Physiol 2012, 112(6):1041-1048.
54. Picard M, Godin R, Sinnreich M, Baril J, Bourbeau J, Perrault H, Taivassalo T, Burelle Y: The mitochondrial phenotype of peripheral muscle in chronic obstructive pulmonary disease: disuse or dysfunction? Am J Respir Crit Care Med 2008, 178(10):1040-1047.
55. Creutzberg EC, Wouters EF, Mastert R, Weling-Scheepers CA, Schols AM: Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition 2003, 19:120-127. (Pubitemid 36196765)
56. Cai BJ, Zhu YY, Ma Y, Xu ZZ, Zao Y, Wang J, Lin Y, Gail M, Comer GM: Effect of supplementing a high-fat, low-carbohydrate enteral formula in COPD patients. Nutrition 2003, 19(3):229-232. (Pubitemid 36279460)
57. Ferreira IM, Brooks D, Lacasse Y, Goldstein RS, White J: Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005, 18 (2):CD000998.
58. Steinert MC, Barton L, Singh SJ, Morgan MD: Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial. Thorax 2003, 58: 745751.
59. Engelen MP, Rutten EP, De Castro CL, Wouters EF, Schols AM, Deutz NE: Casein protein results in higher prandial and exercise induced whole body protein anabolism than whey protein in chronic obstructive pulmonary disease. Metabolism 2012, 61(9):1289-1300.
60. Engelen MP, De De Castro CL, Rutten EP, Wouters EF, Schols AM, Deutz NE: Enhanced anabolic response to milk protein sip feeding in elderly subjects with COPD is associated with a reduced splanchnic extraction of multiple amino acids. Clin Nutr 2012, 31(5):616-624.
61. Dal Negro RW, Testa A, Aquilani R, Tognella S, Pasini E, Barbieri A, Boschi F: Essential amino acid supplementation in patients with severe COPD:a step towards home rehabilitation. Monaldi Arch Chest Dis 2012, 77(2):67-75.
62. Baldi S, Aquilani R, Pinna GD, Poggi P, De Martini A, Bruschi C: Fat-free mass change after nutritional rehabilitation in weight losing COPD: role of insulin C-reactive protein and tissue hypoxia. Int J Chron Obstruct Pulm Dis 2010, 5:2939.
63. Pansarasa O, Flati V, Corsett G, Brocca L: Oral Amino AcidSupplementation Counteracts Age-Induced Sarcopenia in Elderly Rats. Am J Cardiol 2008, 102:S35-41.
64. Allard ML, Jeejeebhoy KN, Sole MJ: The management of conditioned nutritional requirements in heart failure. Heart Fail Rev. 2006, 11:75-82. (Pubitemid 43994886)
65. Witte KK, Clark AL: Micronutrients and their supplementation in chronic cardiac failure: an update beyond theoretical perspectives. Heart Fail Rev. 2006, 11:65-74. (Pubitemid 43986209)
66. Witte KK, Clark AL, Cleland JG: Chronic heart failure and micronutrients. J Am Coll Cardiol 2001, 37:1765-1774. (Pubitemid 32499957)
67. Belardinelli R, Mucaj A, Lacalaprice F, Solenghi M, Principi F, Tiano L, Littarru GP: Coenzyme Q10 improves contractility of dysfunctional myocardium in chronic heart failure. Biofactors 2005, 25:137-145. (Pubitemid 44070841)
68. Belardinelli R, MuçAj A, Lacalaprice F, Solenghi M, Seddaiu G, Principi F, Tiano L, Littarru GP: Coenzyme Q10 and exercise training in chronic heart failure. Eur Heart J 2006, 27:2675-2681.
69. Molyneux SL, Florkowski CM, George PM, Pilbrow AP, Frampton CM, Lever M, Richards AM: Coenzyme Q10: an independent predictor of mortality in chronic heart failure. J Am Coll Cardiol 2008, 52:1435-1441.
70. Mortensen SA: Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of "Q-symbio" - a multinational trial. Biofactors 2003, 18:79-89.
71. Fumagalli S, Fattirolli F, Guarducci L, Cellai T, Baldasseroni S, Tarantini F, Di Bari M, Masotti G, Marchionni N: Coenzyme Q10 Terclatrate and Creatine in Chronic Heart Failure: A Randomized, Placebo-Controlled Double-Blind Study. Clin Cardiol 2011, 34(4):211-217.